Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality

Cristiane M. Ida, Kristen A. Rolig, Rachael L. Hulshizer, Daniel L. Van Dyke, Jamie L. Randolph, Robert B. Jenkins, Antonio G. Nascimento, Andre M. Oliveira

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare, low-grade sarcoma characterized by distinctive, large, and bizarre Reed-Sternberg-like cells associated with an intense inflammatory infiltrate. The biology of MIFS is still poorly understood, and only two previous cases had been studied cytogenetically. In the present case, analysis of MIFS in the foot of a 53-year-old man revealed the chromosome translocation t(2;6)(q31;p21.3) as the only cytogenetic abnormality. This finding is distinct from the two cases previously reported. Additional studies are needed to verify whether any of these chromosome rearrangements are involved recurrently in MIFS.

Original languageEnglish (US)
Pages (from-to)139-142
Number of pages4
JournalCancer Genetics and Cytogenetics
Volume177
Issue number2
DOIs
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality'. Together they form a unique fingerprint.

  • Cite this

    Ida, C. M., Rolig, K. A., Hulshizer, R. L., Van Dyke, D. L., Randolph, J. L., Jenkins, R. B., Nascimento, A. G., & Oliveira, A. M. (2007). Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality. Cancer Genetics and Cytogenetics, 177(2), 139-142. https://doi.org/10.1016/j.cancergencyto.2007.05.018